Immunization

In part 2 of our interview, Rich Tremonte of AmerisourceBergen discusses distribution highlights, inspiring efforts from pharmacists, and the future of COVID-19 vaccination.

The FDA has made revisions to the emergency use authorization for the Moderna COVID-19 vaccine.

Store owners offer tips for supplying and giving shots.

The vaccine is 91.3% effective against COVID-19 for up to 6 months after the second dose, according to an analysis of data collected through March 13.

Pfizer/BioNTech released data on their COVID-19 vaccine that indicates high efficacy in children aged 12 to 15 years.

A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.

A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.

The updated analyses of the AZD1222 COVID-19 vaccine will be submitted to the FDA for emergency use authorization, according to AstraZeneca.

A recent study looked at the role of the influenza vaccine in COVID-19 susceptibility and severity

AstraZeneca responded to the concerns by promising to release the most up-to-date data within 48 hours.

Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose.

AstraZeneca is preparing to submit its COVID-19 vaccine data to the FDA for emergency use authorization in the coming weeks.

The CDC reported data demonstrating high adherence to COVID-19 vaccine doses among recipients.

Germany, Spain, Ireland, and France, among other EU countries, have decided to temporarily suspend the AstraZeneca COVID-19 vaccine amid reports of serious cases of blood clots.

NCPA lauded the higher reimbursement rate in a statement.

New survey results released by NCPA suggest that many Americans prefer to receive the COVID-19 vaccine from a local health care provider over a mass vaccination event.

Are we doing enough to protect those on the front lines?

The CDC has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for COVID-19.

In an opinion piece, pharmacist Pete Kreckel highlights the ways that women have been leading the COVID-19 vaccination effort.

Pharmacies can leverage technology for their workflow and system management. Here’s how.

President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May.

Preliminary findings suggest patients with multiple sclerosis who are taking cladribine can mount and maintain effective vaccine responses.

The FDA is allowing more flexible storage and transportation conditions for Pfizer-BioNTech’s COVID-19 vaccine.